Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyRapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltrationCopper Homeostasis for the Developmental Progression of Intraerythrocytic Malarial ParasiteStimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.Targeting angiogenesis with integrative cancer therapies.Copper and angiogenesis: unravelling a relationship key to cancer progression.The content of selected metals in muscles of the red deer (Cervus elaphus) from PolandMicronized Copper Wood Preservatives: Efficacy of Ion, Nano, and Bulk Copper against the Brown Rot Fungus Rhodonia placenta.Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.Multifocal angiostatic therapy: an update.Toward a core nutraceutical program for cancer management.Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferationHypoxia induces copper stable isotope fractionation in hepatocellular carcinoma, in a HIF-independent manner.Orange protein from Desulfovibrio alaskensis G20: insights into the Mo-Cu cluster protein-assisted synthesis.The Content of Copper and Molybdenum in the Liver, Kidneys, and Skeletal Muscles of Elk (Alces alces) from North-Eastern PolandSynthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.In vitro changes in porcine ovarian granulosa cells induced by copper.Aspergillus fumigatus Copper Export Machinery and Reactive Oxygen Intermediate Defense Counter Host Copper-Mediated Oxidative Antimicrobial Offense.
P2860
Q22299231-AFDC8D10-0195-4FD9-BD1B-D3AAF3963195Q27307762-14DA5D6A-2B56-4DBC-BF05-7578A5A02350Q28067773-9B26C747-8786-41AF-9A3E-48843E5A232CQ33634686-4E0F4C3D-4178-4C1E-8786-7EAC520FEC58Q34495463-9E00FD4F-D31E-449F-9E5C-7C4D53C2B518Q34503515-7507FC02-E545-402C-A452-192C6D401252Q35638465-4EDF7545-382A-4BA9-8924-E3EB356051ACQ35837053-736D8A4E-AC3A-46B7-BB33-D6E4703868FEQ35840331-6E5E2A21-6004-4A6E-8B0F-E99FCACD0AF8Q36311166-B9CEF266-C87A-45D5-A035-D8F3BBA81297Q36473648-26F12ADA-E1F5-4662-9DC7-E05A40ED37BEQ39261217-4C553616-D721-49B1-BA66-7670738D1D10Q39513724-7F4568EB-4B6C-421B-A7CD-302659CF8B64Q40125728-0AE54CE9-EEF8-4FE0-8D26-23103349E1F4Q40750452-C210F15C-0FE9-45BA-82A0-788F9B669DB1Q41200507-8F06E636-D9B0-4551-A95E-93A19683685AQ42706903-E9AB267E-11C5-471A-9563-C318FDB82095Q51152833-C0D675AE-DDA3-46C8-A132-17FBAA1A31B5
P2860
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@ast
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@en
type
label
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@ast
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@en
prefLabel
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@ast
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@en
P356
P1476
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
@en
P2093
George J Brewer
P304
P356
10.2174/1568009053765807
P577
2005-05-01T00:00:00Z